PRESCRIPTION DRUGS – Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers.

Idaho's H 385 establishes rules for pharmaceutical manufacturers regarding the federal 340B drug pricing program. It prohibits manufacturers from interfering with covered entities (like hospitals) or contract pharmacies receiving or dispensing 340B drugs, including restricting access, limiting pharmacy contracts, or demanding unnecessary data as a condition for drug sales. The law aligns with federal 340B requirements but clarifies that manufacturers cannot impose extra restrictions beyond federal rules. The bill takes effect July 1, 2025, and automatically expires if the federal 340B program ends.